-
EP3209297
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3209297
| EP3209297 - AMORPHOUS VORTIOXETINE HYDROBROMIDE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.11.2018 Database last updated on 04.11.2024 | |
| Former | Examination is in progress Status updated on 02.03.2018 | ||
| Former | Request for examination was made Status updated on 28.07.2017 | ||
| Former | The international publication has been made Status updated on 21.04.2017 | Most recent event Tooltip | 30.11.2018 | Application deemed to be withdrawn | published on 02.01.2019 [2019/01] | Applicant(s) | For all designated states Hexal Aktiengesellschaft Industriestrasse 25 83607 Holzkirchen / DE | [2017/35] | Inventor(s) | 01 /
OPPELT, Renate c/o Hexal AG Industriestr. 25 83607 Holzkirchen / DE | [2017/35] | Representative(s) | Prüfer & Partner mbB Patentanwälte · Rechtsanwälte Sohnckestraße 12 81479 München / DE | [2017/35] | Application number, filing date | 15794092.5 | 23.10.2015 | [2017/35] | WO2015EP74607 | Priority number, date | EP20140190357 | 24.10.2014 Original published format: EP 14190357 | [2017/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016062860 | Date: | 28.04.2016 | Language: | EN | [2016/17] | Type: | A1 Application with search report | No.: | EP3209297 | Date: | 30.08.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.04.2016 takes the place of the publication of the European patent application. | [2017/35] | Search report(s) | International search report - published on: | EP | 28.04.2016 | Classification | IPC: | A61K31/495, A61P25/00, A61K9/20 | [2017/35] | CPC: |
A61K31/495 (EP,US);
A61K9/143 (EP,US);
A61K9/146 (EP,US);
A61K9/2031 (EP,US);
A61K9/2054 (EP,US);
A61K9/2095 (EP,US);
A61P25/00 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/35] | Title | German: | AMORPHES VORTIOXETINHYDROBROMID | [2017/35] | English: | AMORPHOUS VORTIOXETINE HYDROBROMIDE | [2017/35] | French: | BROMHYDRATE DE VORTIOXÉTINE AMORPHE | [2017/35] | Entry into regional phase | 20.04.2017 | National basic fee paid | 20.04.2017 | Designation fee(s) paid | 20.04.2017 | Examination fee paid | Examination procedure | 20.04.2017 | Examination requested [2017/35] | 20.04.2017 | Date on which the examining division has become responsible | 07.12.2017 | Amendment by applicant (claims and/or description) | 05.03.2018 | Despatch of a communication from the examining division (Time limit: M04) | 17.07.2018 | Application deemed to be withdrawn, date of legal effect [2019/01] | 20.08.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/01] | Fees paid | Renewal fee | 11.10.2017 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [IDY]WO2007144005 (LUNDBECK & CO AS H [DK], et al) [ID] 1-8,10-13 * examples 22, 15; claim 14 * [Y] 9; | [T] - FENG QIAN ET AL, "Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development", JOURNAL OF PHARMACEUTICAL SCIENCES, (20100101), doi:10.1002/jps.22074, ISSN 0022-3549, pages n/a - n/a, XP055023849 [T] * abstract; page 2942 - page 2944 * DOI: http://dx.doi.org/10.1002/jps.22074 | [Y] - JAY P. LAKSHMAN ET AL, "Application of Melt Extrusion in the Development of a Physically and Chemically Stable High-Energy Amorphous Solid Dispersion of a Poorly Water-Soluble Drug", MOLECULAR PHARMACEUTICS, (20081201), vol. 5, no. 6, doi:10.1021/mp8001073, ISSN 1543-8384, pages 994 - 1002, XP055137910 [Y] 9 * page 996 * DOI: http://dx.doi.org/10.1021/mp8001073 | Examination | WO2015166379 | WO2014177491 | WO2016116077 |